Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-26 · accession 0001055726-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-28 | 2023-02-26 | INO | Humeau Laurent | CSO | M - OptEx | — | +68.8K | 194.4K | +55% | — |
| DM | 2023-02-28 | 2023-02-26 | INO | Humeau Laurent | CSO | F - Tax | $1.28 | -27.9K | 175.6K | -14% | -$35.8K |
| DM | 2023-02-28 | 2023-02-26 | INO | Humeau Laurent | CSO | M - OptEx | $0.00 | -68.8K | 92.5K | -43% | $0 |
| D | 2023-02-28 | 2023-02-27 | INO | Humeau Laurent | CSO | A - Grant | $0.00 | +225.0K | 225.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-26 | M | A | 22,544 | — | 157,228 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Common | Common Stock | 2023-02-26 | F | D | 9,069 | $1.28 | 148,159 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-26 | M | A | 46,267 | — | 194,426 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Common | Common Stock | 2023-02-26 | F | D | 18,868 | $1.28 | 175,558 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 22,544 | $0.00 | 22,544 | D | — · — to — | 22,544 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Common Stock Option | 2023-02-27 | A | A | 225,000 | $0.00 | 225,000 | D | $1.24 · 2023-02-27 to 2033-02-27 | 225,000 Common Stock | (F5) The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026. |
| 7 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 46,267 | $0.00 | 92,533 | D | — · — to — | 46,267 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |